# Phase 218 Verification

completed: 2026-04-26
commit: 0a3da69

## Commands

| Command | Result |
|---|---|
| `dotnet test tests\Videra.Core.Tests\Videra.Core.Tests.csproj -c Release --filter "FullyQualifiedName~VideraDoctorRepositoryTests"` before Doctor existed | FAILED as expected; missing script/docs |
| `dotnet test tests\Videra.Core.Tests\Videra.Core.Tests.csproj -c Release --filter "FullyQualifiedName~VideraDoctorRepositoryTests"` after implementation | PASS; 2 passed |
| `pwsh -NoProfile -ExecutionPolicy Bypass -File scripts\Invoke-VideraDoctor.ps1` | PASS; wrote `artifacts/doctor/doctor-summary.txt` and `artifacts/doctor/doctor-report.json` |
| `dotnet test tests\Videra.Core.Tests\Videra.Core.Tests.csproj -c Release --no-build --filter "FullyQualifiedName~VideraDoctorRepositoryTests|FullyQualifiedName~RepositoryLocalizationTests|FullyQualifiedName~PackageDocsContractTests"` | PASS; 21 passed |
| `git diff --check` | PASS; no whitespace errors, only existing line-ending warnings |
| `dotnet build Videra.slnx -c Release` | PASS; 0 errors, 2 pre-existing CS0067 warnings in SurfaceCharts integration tests |

## Residuals

- Doctor validation invocation/reference states remain Phase 219 scope.
- The transparency wording drift noted in Phase 217 remains deferred to Phase 221.
